Bio-Rad Laboratories Inc. ("Bio-Rad") and 10x Genomics, Inc. ("10x Genomics") have reportedly settled
more than 20 separate patent disputes across a multitude of venues and jurisdictions. A copy of the settlement and patent cross-license agreement, which was filed with the SEC, can be accessed here.
Bio-Rad is based in Hercules,
California and develops and manufactures products for the life sciences research and clinical diagnostic markets.
10x Genomics is based in Pleasanton, California
and designs and manufactures gene sequencing technology used in scientific research. At least some of the founders of 10x Genomics were former employees of Bio-Rad.
Very generally, the patent disputes related to technology for the isolation of individual cells for genetic analysis on microscopic droplets.
The Federal Court of Appeal’s recent decision in Promotion in Motion, Inc. (PIM Brands, Inc.) v. Hershey Chocolate & Confectionery LLC offers fresh guidance on how courts evaluate survey evidence…
Industry Minister Mélanie Joly is reportedly evaluating a proposal from the Canadian Intellectual Property Office (“CIPO”) that would accelerate patent applications in artificial intelligence…
Veteran rock photographer, Neil Zlozower, reportedly sued the Rock & Roll Hall of Fame for allegedly using his copyrighted images of Eddie Van Halen in its museum exhibits without his permission…
The U.S. District Court for the Eastern District of Washington (“District Court”) reportedly reinstated the Canadian government’s patent for the “Staccato” cherry, developed by Agriculture and…
As reported by the Associated Press, Columbia Sportswear has sued Columbia University, claiming that the university infringed the sportswear company’s trademark and breached an agreement between the…
Verizon and Headwater Research LLC have reportedly agreed to settle a patent infringement lawsuit that ended with a $175 million USD jury verdict against the telecom giant. Headwater, a…
